Professional Psilocybin Therapy Services in Canada

December 4, 2024

Professional Psilocybin Therapy Services in Canada

Professional Psilocybin Therapy Services in Canada workers are asking a federal court to allow them to consume psilocybin for patient care. The therapists are part of a group that offers psychedelic-assisted psychotherapy as an alternative to traditional medicine for patients with end-of-life psychological distress, treatment-resistant depression and anxiety and other mental illnesses.

The group says consuming the drug in a controlled environment helps them understand the experience and support their clients. They say the experience allows them to empathize with their patients and know when to intervene, or when to leave the person alone. The workers have a list of hundreds of people waiting to be treated, and say denying them access to the drug violates their rights.

Buy Weed at Cheap Prices: Where Quality Meets Affordability

A recent wave of clinical trials have found that psilocybin can help treat PTSD, treatment-resistant depression and end-of-life anxiety in some patients. But controversy has swirled around the use of psychedelics in therapy, with some studies involving abuse allegations and a lack of engagement with Indigenous cultures.

Earlier this year, a court-appointed monitor recommended changing regulations to allow therapists to administer psilocybin under the Special Access Program (SAP) when traditional treatment options have failed or are unsuitable for their patients. But Health Canada rejected the recommendation, saying it doesn’t believe the therapists need to have experience with the drug themselves.